Racial and ethnic disparities in the receipt of cancer treatment.

By V. Shavers, Martin L. Brown. Journal of the National Cancer Institute, 2002

962 citations recorded by the source corpus.

Subfields: Economics and Econometrics, Oncology

View Paper: https://www.semanticscholar.org/paper/8b39a19423c0b29608c26f0549a551a4dd8588b7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Economics and Econometrics

1. A. Jemal
2. R. Siegel
3. K. Miller
4. C. DeSantis
5. Jiemin Ma
6. A. Mariotto
7. Balázs Győrffy

In Oncology

1. A. Jemal
2. R. Siegel
3. K. Miller
4. Elizabeth E. Ward
5. C. DeSantis
6. Jiemin Ma
7. S. Fedewa
8. Robert A. Smith

Citations in the corpus

• Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival (2017, result): “Similarly, compared with whites, AI/AN had higher risk of death for almost all cancer types and Hispanics had higher risk of death for many cancers, which may in part reflect treatment differences (8,93).”
• Trends in Breast Cancer by Race and Ethnicity: Update 2006 (2006, background): “Studies have also documented unequal receipt of prompt, high-quality treatment for African American women compared with White women.(40,41) For example, African American women are less likely to receive radiation therapy following breastconserving surgery.”
• Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities (2016, background): “Much of the difference in survival is believed to be due to barriers that limit access to timely, appropriate, and high-quality medical care.(29-33) Furthermore, blacks are more likely to be diagnosed at later stages of the disease for most cancer sites (Fig.”
• Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival (2004, background): “The limited data available frequently document differences in the receipt of optimal treatment based on socioeconomic status and race/ethnicity, with little evidence that response to treatment varies among racial and ethnic groups when accounting for stage of disease and other important prognostic v”
• Barriers to recruiting underrepresented populations to cancer clinical trials: A systematic review (2008, background): “Racial differences in access to state-of-the-art care contribute to disparities in cancer mortality and survival after cancer diagnosis.(4,11,12) However, these disparities disappear when African Americans and Caucasians receive similar cancer treatment for same-stage disease.”
• Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. (2006, neutral): “Unclassified 31 6 (6) 4 (4) 16 (10) 5 (4)”
• Cancer Disparities by Race/Ethnicity and Socioeconomic Status (2004, background): “A recent comprehensive review found limited evidence that racial and ethnic populations differ in their response to treatment.(39) However, access to high-quality cancer care varies substantially by socioeconomic status and race.”